The cost effectiveness of licensed oromucosal midazolam (Buccolam®) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited

Authors:

Lee D, Gladwell D, Batty AJ, Brereton N and Tate E.

Publication type:

Journal article

Publication name:

Paediatric drugs

Citation:

Lee D, Gladwell D, Batty AJ, Brereton N and Tate E. The cost effectiveness of licensed oromucosal midazolam (Buccolam®) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited. Paediatr Drugs. 2013; 15(2):151-62.

Link to publication ⟶

⟵ Back to Search Results